Epidemiology and Antimicrobial Susceptibility of Bloodstream Infections among Febrile Neutropenic Patients at a Thai University Hospital
Keywords:
Febrile neutropenia, Bloodstream infections, Antimicrobial resistanceAbstract
Background: Febrile neutropenia is a frequent and serious complication in patients undergoing chemotherapy for malignancies, often resulting in significant morbidity and mortality. Understanding local epidemiology and antimicrobial resistance patterns is critical to optimizing empirical therapy for bloodstream infections in this population.
Objective: This study aimed to evaluate the current microbiological profile and antimicrobial susceptibility patterns of bloodstream infections (BSIs) in neutropenic patients at Phramongkutklao Hospital. Additionally, the study sought to identify factors associated with drug-resistant infections and determine their impact on patient mortality.
Materials and Method: This retrospective analytical study reviewed the medical records of febrile neutropenic patients with bloodstream infections at Phramongkutklao Hospital between January 1, 2017, and December 31, 2021. The study aimed to describe the epidemiological trends and antimicrobial susceptibility patterns in febrile neutropenic patients with bacteremia.
Results: A total of 151 febrile neutropenic patients with bloodstream infections were included, with a mean age of 43.42 years. Males constituted 57.6% of the cohort. The most common underlying conditions were acute myeloid leukemia (60.9%), acute lymphoblastic leukemia (25.2%), and multiple myeloma (10.6%). Gram-negative bacteria were the most frequently isolated pathogens (73.5%), primarily Escherichia coli (33.7%), Klebsiella pneumoniae (19.9%), and Pseudomonas aeruginosa (10.6%). Gram-positive bacteria accounted for 19.9% of cases, and fungi 6.6%. Significant associations were observed between urinary catheter use and infections caused by carbapenem-resistant Enterobacterales (CRE) and vancomycin-resistant Enterococci (VRE) (p < 0.05), while parenteral nutrition
use was linked to methicillin-resistant Staphylococcus aureus (MRSA) infections (p = 0.02). The overall 14-day mortality rate was 16.6%, with CRE and VRE infections contributing significantly to mortality (p < 0.01). A Pitt bacteremia score greater than 3 was also identified as a significant predictor of mortality.
Conclusion: Gram-negative bacteria remain the predominant pathogens in febrile neutropenic patients with bloodstream infections. Their prevalence and evolving antimicrobial resistance patterns are critical considerations in guiding empirical therapy at Phramongkutklao Hospital.
References
Rosa RG, Goldani LZ, dos Santos RP. Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study. BMC Infect Dis. 2014; 14: 286. https://doi.org/10.1186/1471-2334-14-286
Klastersky J, De Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016; 27 (suppl 5): v111-v118. https://doi.org/10.1093/annonc/mdw325
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018; 36 (30): 3043-54. https://doi.org/10.1200/JCO.18.00374
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34 (6): 1589-96. https://doi.org/10.1097/01.CCM.0000217961.75225.E9
Ledoux M-P, Guffroy B, Nivoix Y, Simand C, Herbrecht R, editors. Invasive pulmonary aspergillosis. Semin Respir Crit Care Med. 2020; 41 (1): 80-98. https://doi.org/10.1055/s-0039-3401990
Abdel-Azim H, Sun W, Wu LJP, therapeutics. Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy. Pharmacol Ther. 2019; 204: 107403. https://doi.org/10.1016/j.pharmthera.2019.107403
Stephens RS. Neutropenic fever in the intensive care unit. Oncologic Critical Care. 2019: 1297-1311. https://doi.org/10.1007/978-3-319-74588-6_118
Hatamabadi H, Dolatabadi AA, Akhavan A, Safari S. Clinical Characteristics and Associated Factors of Mortality in Febrile Neutropenia Patients; a Cross Sectional Study. Arch Acad Emerg Med. 2019; 7 (1): 39.
Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013; 19 (5): 474-9. https://doi.org/10.1111/j.1469-0691.2012.03879.x
Kokkayil P, Agarwal R, Mohapatra S, Bakshi S, Das B, Sood S, et al. Bacterial profile and antibiogram of blood stream infections in febrile neutropenic patients with haematological malignancies. J Infect Dev Ctries. 2018; 12 (6): 442-7. https://doi.org/10.3855/jidc.9725
Roongpoovapatr P, Suankratay C. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2010; 93 (7):776-83.
Taj M, Farzana T, Shah T, Maqsood S, Ahmed S, Shamsi TS. Clinical and microbiological profile of pathogens in febrile neutropenia in hematological malignancies: a single center prospective analysis. J Oncol. 2015; 2015: 596504. https://doi.org/10.1155/2015/596504
Zimmer AJ, Stohs E, Meza J, Arnold C, Baddley JW, Chandrasekar P, et al., editors. Bloodstream infections in hematologic malignancy patients with fever and neutropenia: are empirical antibiotic therapies in the United States still effective? Open Forum Infect Dis. 2022; 9 (7): ofac240. https://doi.org/10.1093/ofid/ofac240
Alves J, Abreu B, Palma P, Alp E, Vieceli T, Rello J. Antimicrobial stewardship on patients with neutropenia: A narrative review commissioned by microorganisms. Microorganisms. 2023; 11 (5):1127. https://doi.org/10.3390/microorganisms11051127
Balkhair A, Al-Muharrmi Z, Al'Adawi B, Al Busaidi I, Taher H, Al-Siyabi T, et al. Prevalence and 30-day all-cause mortality of carbapenem-and colistinresistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decade-long trend. Int J Infect Dis. 2019: 85:10-15. https://doi.org/10.1016/j.ijid.2019.05.004
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2011; 52 (4): e56-e93, https://doi.org/10.1093/cid/cir073
CLSI M100. Performance Standards for Antimicrobial Susceptibility Testing, 33rd Edition 2023 [Available from: https://clsi.org/standards/products/microbiology/documents/ m100.
Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, et al. The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clin Infect Dis. 2020; 70 (9): 1826-33. https://doi.org/10.1093/cid/ciz528
Rhee J-Y, Kwon KT, Ki HK, Shin SY, Jung DS, Chung D-R, et al. Scoring systems for prediction of mortality in patients with intensive care unitacquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009; 31 (2):146-50. https://doi.org/10.1097/SHK.0b013e318182f98f
Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents. 2008: 32 Suppl 1: S30-3. https://doi.org/10.1016/j.ijantimicag.2008.06.017
Jesudason T. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe. 2024; 5: 100940. https://doi.org/10.1016/j.lanmic.2024.07.003
WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Available from: https://iris.who.int/bitstream/handle/10665/376776/9789240093461-eng.pdf?sequence=1.
Auesomwang C, Suwannawiboon B, Chayakulkeeree M. Changes in Etiologic Microorganisms in Thai Patients with Chemotherapy-Induced Neutropenia and Fever. J Med Assoc Thai. 2018; 101 (2): 173-80.
Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Cueto Md, Ríos MJ, et al. Bacteremia due to extended-spectrum β-lactamase- producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis. 2006; 43 (11): 1407-14. https://doi.org/10.1086/508877
Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. 2024; ciae 403. https://doi.org/10.1093/cid/ciae403
Shein AMS, Wannigama DL, Higgins PG, Hurst C, Abe S, Hongsing P, et al. High prevalence of mgrB-mediated colistin resistance among carbapenemresistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy. Scientific Reports. 2022; 12 (1):12939. https://doi.org/10.1038/s41598-022-17083-5
Chirabhundhu N, Luk-In S, Phuadraksa T, Wichit S, Chatsuwan T, Wannigama DL, et al. Occurrence and mechanisms of tigecycline resistance in carbapenemand colistin-resistant Klebsiella pneumoniae in Thailand. Scientific Reports. 2024; 14 (1): 5215. https://doi.org/10.1038/s41598-024-55705-2
Phungtaharn T, Rungviriyavanich O, Klubchareon S, Susaengrat W. Febrile neutropenia at Khon Kaen Hospital. Khon Kaen Medical Journal. 2006; 30:111-21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Greater Mekong Subregion Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
